Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Urbanicity, Psychosis, and Developing Countries

JAMA Psychiatry; ePub 2018 May 16; DeVylder, et al

Urbanicity, a well-established risk factor for psychosis, may not be associated with elevated odds for psychosis in developing countries, according to a recent study. This international population-based study used cross-sectional survey data collected as part of the World Health Organization (WHO) World Health Survey from May 2, 2002, through December 31, 2004. Participants included nationally representative general population probability samples of adults (≥18 years) residing in 42 low- and middle-income countries (LMICs) (n=215,682). Researchers found:

  • Among total participants (50.8% women and 49.2% men; mean [SD] age, 37.9 [15.7] years), urban residence was not associated with psychotic experiences or psychotic disorder.
  • Results of all pooled analyses and meta-analyses of within-country effects approached a null effect, with overall odds ratio (OR) of 0.97, OR for low-income countries of 0.98, and OR for middle-income countries of 0.96 for psychotic experiences, and an overall OR of 0.92, OR for low-income countries of 0.92, and OR for middle-income countries of 0.92 for psychotic disorder.

Citation:

DeVylder JE, Kelleher I, Lalane M, Link BG, Koyanagi A. Association of urbanicity with psychosis in low- and middle-income countries. [Published online ahead of print May 16, 2018]. JAMA Psychiatry. doi:10.1001/jamapsychiatry.2018.0577.

This Week's Must Reads

Folic Acid Exposure Linked with Psychosis Reduction, JAMA Psychiatry; ePub 2018 Jul 3; Eryilmaz, et al

Increasing Trend of Naloxone Use in the US, Addiction; ePub 2018 Jul 10; Rege, Ngo, et al

Antipsychotic Use Examined Across Wide Age Range, Int J Geriatr Psych; ePub 2018 Jul 8; Jester, et al

FDA Approves New Dosing Formulation for Nuplazid, Acadia Pharmaceuticals Inc. news release; 2018 Jun 29

Midlife Fitness Linked with Lower Depression Risk , JAMA Psychiatry; ePub 2018 Jun 27; Willis, et al

Must Reads in Schizophrenia & Other Psychotic Disorders

Folic Acid Exposure Linked with Psychosis Reduction, JAMA Psychiatry; ePub 2018 Jul 3; Eryilmaz, et al

FDA Approves New Dosing Formulation for Nuplazid, Acadia Pharmaceuticals Inc. news release; 2018 Jun 29

FDA Approves Initiation Drug for Schizophrenia, Alkermes plc news release; 2018 Jul 2

Measuring Psychotic-like Experiences in Childhood , JAMA Psychiatry; ePub 2018 Jun 6; Karcher, et al

The Significance of Psychosis in BD, Schizophrenia, Bipolar Disord; ePub 2018 May 18; Bowie, et al